U.S. Urology Partners First in Region to Provide Minimally Invasive Aquablation Procedure for Enlarged Prostate at Central Ohio Urology Group
COLUMBUS, Ohio & NASHVILLE, Tenn.–(BUSINESS WIRE)–Half of all men over the age of 50 struggle with a decreased quality of life due to benign prostatic hyperplasia (BPH), also known as enlarged prostate. At Central Ohio Urology Group, an affiliate of U.S. Urology Partners, an innovative, minimally invasive procedure called Aquablation is changing that for patients. Dr. Scott D. Barkin of Central Ohio Urology Group is one of the most experienced Aquablation experts in Ohio and surrounding states, and has performed the procedure for more than 100 patients.
BPH is a non-cancerous condition where the prostate has grown to be larger than normal. One in two men between the ages of 51 and 60 have BPH, and the incidence increases each decade of life such that by age 80, 90% of men will have BPH. If left untreated, BPH can cause significant health problems, including irreversible bladder or kidney damage, bladder stones, UTIs and incontinence, as well as inability or difficulty urinating, or urinating often.
Aquablation therapy combines real-time, multi-dimensional imaging, automated robotic technology and heat-free waterjet ablation for targeted, controlled and immediate removal of prostate tissue. Because there isn’t heat involved with the treatment, Aquablation has less effect on the structures around the prostate, helping to preserve sexual function in most patients.
“Improved quality of life is the key benefit for our BPH patients,” says Dr. Scott D. Barkin of Central Ohio Urology Group, an affiliate of U.S. Urology Partners. “Typically, our patients are seeking better urination by removing an existing indwelling catheter, eliminating their prostate medication or achieving a better night’s sleep with fewer trips to the restroom. When compared with similar treatments for BPH, Aquablation tries to spare the men’s ejaculatory function, removes more prostate tissue in a shorter time and therefore requires less anesthesia, and is only one of a few treatments designed for large prostates.”
Aquablation therapy, like similar therapies for large prostates, is performed in a hospital and is done under anesthesia. The procedure typically takes around 60 to 90 minutes (less for smaller prostates; more for larger prostates) and may involve an overnight stay depending on the size of the prostate. No incision is necessary, as the prostate is reached through the urethra.
Other BPH surgical treatments often force men to compromise between symptom relief and side effects. Patients choosing a high degree of symptom relief face possible complications such as incontinence, erectile dysfunction or ejaculatory dysfunction.
Central Ohio Urology Group physicians performing Aquablation therapy include Dr. Scott D. Barkin, Dr. William E. Bloch and Dr. Adam C. Weiser. To discuss treatment options for BPH, contact the group at 614.396.2684.
About U.S. Urology Partners
U.S. Urology Partners is one of the nation’s largest independent providers of urology and related specialty services, including general urology, surgical and robotic procedures, advanced cancer treatment and other ancillary services. The U.S. Urology Partners clinical network consists of more than 50 locations throughout the East Coast and Midwest. U.S. Urology Partners was formed to support urology practices with an experienced team of healthcare executives and resources, and is backed by NMS Capital. The U.S. Urology Partners corporate office is in Nolensville, Tennessee, just outside of Nashville. For additional information about U.S. Urology Partners, please visit www.us-uro.com.
Contacts
Media Contact:
Laura Campbell
CEO, Laura Campbell & Associates
615.579.6599
[email protected]
